Q122 proved to be a mixed-bag of ups and downs with supply chain issues and Covid surges having varying ...
Although revenues still show signs of COVID-19 impact, robotic procedures and implant pull-through accel...
Improved aspiration systems, large-bore catheters, balloon-guide catheters and radial access top the lis...
Covid-related challenges continued to dampen market recovery in Q321. Despite pandemic hurdles, technolo...
Login